CRM1 inhibition

CRM1 inhibition has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 13, 2021: “Enhanced Activity of Exportin-1/CRM1 in Neurons Contributes to Autophagy Dysfunction and Senescent Features in Old Mouse Brain”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on CRM1 inhibition

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Comisión Nacional de Investigación Científica y Tecnológica and 5 more
  • Animals1

What did studies of CRM1 inhibition find?

2

Studies of CRM1 inhibition measured 2 outcomes: senescence-associated beta-galactosidase and autophagy.

Senescence-associated beta-galactosidase

downin mouse cells1

1 study
  1. CRM1 inhibition decreases senescence-associated beta-galactosidase in vitro model of neuronal senescence.

    “CRM1 inhibition improved autophagy flux and reduced SA-β-gal activity by restoring TFEB nuclear localization”

    Cellsin vitro model of neuronal senescence

    Enhanced Activity of Exportin-1/CRM1 in Neurons Contributes to Autophagy Dysfunction and Senescent Features in Old Mouse Brain

    Oxidative medicine and cellular longevity

More on Senescence-associated beta-galactosidase

Autophagy

upin mouse cells1

1 study
  1. CRM1 inhibition increases autophagy in vitro model of neuronal senescence.

    “CRM1 inhibition improved autophagy flux and reduced SA-β-gal activity by restoring TFEB nuclear localization”

    Cellsin vitro model of neuronal senescence

    Enhanced Activity of Exportin-1/CRM1 in Neurons Contributes to Autophagy Dysfunction and Senescent Features in Old Mouse Brain

    Oxidative medicine and cellular longevity

More on Autophagy

Latest